People with co-morbidities, including diabetes and hypertension, who are treated with the drugs such as thiazolidinediones, angiotensin-converting enzyme (ACE) inhibitors, and angiotensin-II receptor blockers (ARBs) have an increased expression of angiotensin-converting enzyme-2 (ACE-2). Here, ACE2 is linked to hypertensive disorder.